Table IV.
RIZ1 methylation | RASSF1A methylation | |||||
---|---|---|---|---|---|---|
Clinicopathology | - | + | P-value | - | + | P-value |
Gender | 0.492 | 0.665 | ||||
Male | 8 | 19 | 3 | 24 | ||
Female | 3 | 5 | 1 | 7 | ||
Age (years) | 0.521 | 0.372 | ||||
≤50 | 3 | 8 | 2 | 9 | ||
>50 | 8 | 16 | 2 | 22 | ||
AFP (µg/l) | 0.626 | 0.522 | ||||
≤20 | 4 | 9 | 1 | 12 | ||
>20 | 7 | 15 | 3 | 19 | ||
Tumor size (cm) | 0.352 | 0.630 | ||||
≤5 | 7 | 12 | 2 | 17 | ||
>5 | 4 | 12 | 2 | 14 | ||
Cirrhosis | 0.144 | 0.478 | ||||
+ | 5 | 17 | 2 | 20 | ||
- | 6 | 7 | 2 | 11 | ||
HbsAg | 0.619 | 0.609 | ||||
+ | 9 | 19 | 3 | 25 | ||
- | 2 | 5 | 1 | 6 | ||
Capsular invasion | 0.281 | 0.200 | ||||
+ | 5 | 15 | 1 | 19 | ||
- | 6 | 9 | 3 | 12 | ||
Distal metastasis | 0.309 | 0.681 | ||||
+ | 2 | 8 | 1 | 9 | ||
- | 9 | 16 | 3 | 22 | ||
Differentiation | 0.619 | 0.609 | ||||
High to medium | 9 | 19 | 3 | 25 | ||
Poor | 2 | 5 | 1 | 6 |
HCC, hepatocellular carcinoma; AFP, α-fetoprotein; HbsAg, hepatitis B surface antigen.